Skip to main content
Premium Trial:

Request an Annual Quote

Life After NIH

Elias Zerhouni, the head of NIH during the Bush administration, is taking on a new role. He will be heading up global R&D at Sanofi-Aventis, reports Fierce Biotech. Zerhouni is replacing Marc Cluzel who resigned. Since leaving NIH, Zerhouni has consulted for Sanofi-Aventis, served on the boards of the Mayo Clinic and the Lasker Foundation, and worked at the Bill and Melinda Gates Foundation and Johns Hopkins University, adds Nature's The Great Beyond blog. "I have had the privilege of working with Elias for a long time. Through his vast experience and visionary approach, he has provided excellent advice and insight and has been central in implementing what is now one of the most promising R&D models in healthcare," says Sanofi-Aventis CEO Christopher Viehbacher in a statement.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.